Health Catalyst, Inc.
HCAT
$3.79
-$0.025-0.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.28% | 6.02% | 3.50% | 3.67% | 1.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.28% | 6.02% | 3.50% | 3.67% | 1.16% |
| Cost of Revenue | 9.15% | 5.18% | 1.18% | 1.46% | 1.10% |
| Gross Profit | 3.29% | 7.13% | 6.50% | 6.23% | 1.22% |
| SG&A Expenses | -13.78% | -9.83% | -16.62% | -13.80% | 1.90% |
| Depreciation & Amortization | 17.05% | -0.37% | -2.03% | -0.73% | -4.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.31% | -2.71% | -7.95% | -7.43% | -1.98% |
| Operating Income | 24.47% | 32.57% | 45.61% | 44.62% | 13.17% |
| Income Before Tax | -14.91% | 33.55% | 30.82% | 58.66% | 38.18% |
| Income Tax Expenses | 90.27% | 337.06% | -905.08% | -17.65% | 63.77% |
| Earnings from Continuing Operations | -15.33% | 31.80% | 33.16% | 58.56% | 37.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.33% | 31.80% | 33.16% | 58.56% | 37.97% |
| EBIT | 24.47% | 32.57% | 45.61% | 44.62% | 13.17% |
| EBITDA | 57.77% | 48.81% | 67.11% | 71.67% | 17.27% |
| EPS Basic | 1.45% | 37.16% | 37.30% | 60.88% | 41.26% |
| Normalized Basic EPS | 7.49% | 17.35% | 35.10% | 53.49% | 21.68% |
| EPS Diluted | 1.45% | 37.16% | 37.30% | 60.88% | 41.26% |
| Normalized Diluted EPS | 7.49% | 17.35% | 35.10% | 53.49% | 21.68% |
| Average Basic Shares Outstanding | 17.00% | 8.53% | 6.58% | 5.94% | 5.60% |
| Average Diluted Shares Outstanding | 17.00% | 8.53% | 6.58% | 5.94% | 5.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |